Related references
Note: Only part of the references are listed.Age-Related Changes in Female Scalp Dermal Sheath and Dermal Fibroblasts: How the Hair Follicle Environment Impacts Hair Aging
Rachael Williams et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
ADSCs enhance VEGFR3-mediated lymphangiogenesis via METTL3-mediated VEGF-C m6A modification to improve wound healing of diabetic foot ulcers
Jie Zhou et al.
MOLECULAR MEDICINE (2021)
Fibroblastic reticular cell response to dendritic cells requires coordinated activity of podoplanin, CD44 and CD9
Charlotte M. de Winde et al.
JOURNAL OF CELL SCIENCE (2021)
Ixekizumab May Improve Renal Function in Psoriasis
Giuseppe Fabrizio Amoruso et al.
HEALTHCARE (2021)
Primary Mucosal Melanoma Presenting with a Unilateral Nasal Obstruction of the Left Inferior Turbinate
Nicola Lombardo et al.
MEDICINA-LITHUANIA (2021)
The Correlation Between Immunohistochemistry Findings and Metastasis in Squamous Cell Carcinoma: A Review
Marissa Lobl et al.
DERMATOLOGIC SURGERY (2021)
The Prognostic Value of Podoplanin Expression in Nonmelanoma Skin Cancers: Correlation With Lymphatic Vessel Density
Yomna Mazid El-Hamd Neinaa et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2020)
Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report
Maria Passante et al.
DERMATOLOGIC THERAPY (2020)
Cutaneous lymphoma in Japan, 2012-2017: A nationwide study
Kazuyasu Fujii et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma
Masahiro Shinada et al.
CELLS (2020)
Keratinocyte-Expressed Podoplanin is Dispensable for Multi-Step Skin Carcinogenesis
Marko Sesartic et al.
CELLS (2020)
Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method
Takahiro Arita et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Podoplanin expression in cutaneous squamous cell carcinomas and its relationship to histopathological prognostic factors
Duygu Gulseren et al.
JOURNAL OF HISTOTECHNOLOGY (2020)
Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
Lucia Montero-Montero et al.
CELLS (2020)
Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma
Satoshi Kamoto et al.
CELLS (2020)
Podoplanin as a Predictive Marker for Identification of High-Risk Mycosis Fungoides Patients: An Immunohistochemical Study
Amal A. El-Ashmawy et al.
INDIAN JOURNAL OF DERMATOLOGY (2020)
Podoplanin in Inflammation and Cancer
Miguel Quintanilla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Psoriasis Pathogenesis and Treatment
Adriana Rendon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Single-Cell Analysis Reveals Heterogeneity of High Endothelial Venules and Different Regulation of Genes Controlling Lymphocyte Entry to Lymph Nodes
Krystle Veerman et al.
CELL REPORTS (2019)
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma
Yasuhiro Fujisawa et al.
CANCER MEDICINE (2019)
Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma
Mengqiao Xu et al.
BMC CANCER (2019)
Suppression of podoplanin expression during differentiation of epidermal keratinocytes
Masaru Honma et al.
JOURNAL OF DERMATOLOGY (2019)
An important role of podoplanin in hair follicle growth
Sun-Young Yoon et al.
PLOS ONE (2019)
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin
Katsue Suzuki-Inoue
BLOOD (2019)
Podoplanin suppresses the cell adhesion of epidermal keratinocytes via functional regulation of 1-integrin
Takashi Shibuya et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2019)
Platelet CLEC-2: Roles Beyond Hemostasis
Katsue Suzuki-Inoue et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Lymphatic Dysfunction, Leukotrienes, and Lymphedema
Xinguo Jiang et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction
Nagaharu Tsukiji et al.
BLOOD (2018)
Podoplanin: An emerging cancer biomarker and therapeutic target
Harini Krishnan et al.
CANCER SCIENCE (2018)
Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma
Kousuke Sasaki et al.
HUMAN PATHOLOGY (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis
T. Sasaki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
The role of podoplanin in cancer-associated thrombosis
Pegah Mir Seyed Nazari et al.
THROMBOSIS RESEARCH (2018)
Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice
Nagaharu Tsukiji et al.
BLOOD ADVANCES (2018)
Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes
Roberta Bianchi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma
Javier Canueto et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease
Zaigen Cho et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood
K. Suzuki-Inoue et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis
Robert J. Eddy et al.
TRENDS IN CELL BIOLOGY (2017)
Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization
Anna Tejchman et al.
Oncotarget (2017)
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Kenichi Miyata et al.
SCIENTIFIC REPORTS (2017)
Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity
Mika K. Kaneko et al.
CANCER MEDICINE (2017)
Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancerassociated fibroblasts in breast cancer progression
Jaroslaw Suchanski et al.
PLOS ONE (2017)
A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis
Ai Takemoto et al.
SCIENTIFIC REPORTS (2017)
Hair follicle-associated-pluripotent (HAP) stem cells
Yasuyuki Amoh et al.
CELL CYCLE (2017)
Podoplanin is a negative regulator of Th17 inflammation
Alyssa N. Nylander et al.
JCI INSIGHT (2017)
Platelet-activating factor podoplanin: from discovery to drug development
Ai Takemoto et al.
CANCER AND METASTASIS REVIEWS (2017)
Podoplanin Expression Correlates with Disease Progression in Mycosis Fungoides
Alina Jankowska-Konsur et al.
ACTA DERMATO-VENEREOLOGICA (2017)
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis
Takaya Sekiguchi et al.
ONCOTARGET (2016)
Platelets Regulate the Migration of Keratinocytes via Podoplanin/CLEC-2 Signaling during Cutaneous Wound Healing in Mice
Jun Asai et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells
Tao Yin et al.
CELLULAR IMMUNOLOGY (2016)
Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells
M. Noack et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity
Sudjit Luanpitpong et al.
SCIENTIFIC REPORTS (2016)
PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility
Harini Krishnan et al.
EXPERIMENTAL CELL RESEARCH (2015)
Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation
Tatsuya Yoshida et al.
CLINICAL CANCER RESEARCH (2015)
The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture
Jillian L. Astarita et al.
NATURE IMMUNOLOGY (2015)
Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability
E. Martin-Villar et al.
ONCOGENE (2015)
Podoplanin expression in cancer-associated fibroblasts predicts aggressive behavior in melanoma
Saori Kan et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2014)
Dendritic cells control fibroblastic reticular network tension and lymph node expansion
Sophie E. Acton et al.
NATURE (2014)
The Effect of Podoplanin Inhibition on Lymphangiogenesis Under Pathological Conditions
Yuko Maruyama et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Extracellular heat shock protein A9 is a novel interaction partner of podoplanin in oral squamous cell carcinoma cells
Masayuki Tsuneki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Thymic medullar conduits-associated podoplanin promotes natural regulatory T cells
Elke Fuertbauer et al.
IMMUNOLOGY LETTERS (2013)
Podoplanin expression is inversely correlated with granular layer/filaggrin formation in psoriatic epidermis
Masaru Honma et al.
JOURNAL OF DERMATOLOGY (2013)
Update of Immune Events in the Murine Contact Hypersensitivity Model: Toward the Understanding of Allergic Contact Dermatitis
Tetsuya Honda et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
Satoshi Takagi et al.
PLOS ONE (2013)
The physiological and pathophysiological roles of platelet CLEC-2
Leyre Navarro-Nunez et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Topical Simvastatin Accelerates Wound Healing in Diabetes by Enhancing Angiogenesis and Lymphangiogenesis
Jun Asai et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity
Suguru Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Podoplanin-Rich Stromal Networks Induce Dendritic Cell Motility via Activation of the C-type Lectin Receptor CLEC-2
Sophie E. Acton et al.
IMMUNITY (2012)
Podoplanin expression in wound and hyperproliferative psoriatic epidermis: Regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22
Masaru Honma et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks
Deepali Malhotra et al.
NATURE IMMUNOLOGY (2012)
Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration
Jhon Alberto Ochoa-Alvarez et al.
PLOS ONE (2012)
Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression
Ayuko Hoshino et al.
CANCER RESEARCH (2011)
DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling
Orna Tal et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Evaluation of lymphangiogenic markers in Se,zary syndrome
Maria B. Karpova et al.
LEUKEMIA & LYMPHOMA (2011)
High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma
Hanako Suzuki et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Prognostic and Risk Factors in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma of the Trunk and Extremities
de Lima Vazquez Vinicius et al.
JOURNAL OF SKIN CANCER (2011)
Immunolabeling Pattern of Podoplanin (D2-40) May Distinguish Basal Cell Carcinomas From Trichoepitheliomas: A Clinicopathologic and Immunohistochemical Study of 49 Cases
Jose A. Plaza et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2010)
Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling
Cara C. Bertozzi et al.
BLOOD (2010)
Podoplanin Associates with CD44 to Promote Directional Cell Migration
Ester Martin-Villar et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung
Yoshihisa Shimada et al.
CANCER SCIENCE (2009)
Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions
Leah N. Cueni et al.
EXPERIMENTAL CELL RESEARCH (2009)
Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies
Takeo Ito et al.
LUNG CANCER (2009)
Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis
Youya Nakazawa et al.
BLOOD (2008)
Cardiac malformations and myocardial abnormalities in Podoplanin knockout mouse embryos:: Correlation with abnormal epicardial development
Edris A. F. Mahtab et al.
DEVELOPMENTAL DYNAMICS (2008)
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Guifang Cai et al.
NATURE IMMUNOLOGY (2008)
Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells
Alexander Link et al.
NATURE IMMUNOLOGY (2007)
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing
Kazuichi Maruyama et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes
Marc Bajenoff et al.
IMMUNITY (2006)
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition
Ester Martin-Villar et al.
JOURNAL OF CELL SCIENCE (2006)
Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor
Mika Kato Kaneko et al.
GENE (2006)
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome
Ping Yuan et al.
CANCER (2006)
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors
V Schacht et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas
E Martín-Villar et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node
M Sixt et al.
IMMUNITY (2005)
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix
KL Dumoff et al.
MODERN PATHOLOGY (2005)
Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors
Y Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
V Schacht et al.
EMBO JOURNAL (2003)
Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression
FG Scholl et al.
LABORATORY INVESTIGATION (2000)
Share Paper
